干扰素诱导跨膜蛋白的抗病毒研究进展

新发传染病电子杂志 ›› 2020, Vol. 5 ›› Issue (2): 122-125.

干扰素诱导跨膜蛋白的抗病毒研究进展

李浩民, 吴诗品

暨南大学第二临床医学院、深圳市人民医院感染内科,广东深圳 518020

收稿日期:2019-11-06 出版日期:2020-02-20 发布日期:2020-06-19
通讯作者: 吴诗品,Email：wupoem@126.com
基金资助:
深圳市政府三名工程项目（SZSJ2018018）

Research on antiviral progress of interferon-induced transmembrane protein

Li Haomin, Wu Shipin

Department of Infectious Diseases,the Second Clinical Medical College of Jinan University, Shenzhen People's Hospital, Guangdong Shenzhen 518020, China

Received:2019-11-06 Online:2020-02-20 Published:2020-06-19

摘要/Abstract

摘要： 干扰素（interferon,IFN）受外界刺激后可与细胞干扰素受体特异性结合,该信号通路的活化可诱导数百个干扰素刺激基因（interferon stimulated genes,ISGs）的表达,编码多种先天性免疫分子,从而启动或调节机体的免疫应答。干扰素诱导的跨膜蛋白（interferon-induced transmembrane protein,IFITM）正是一种重要的ISGs分子,它在抗病毒免疫、肿瘤形成、骨质代谢、细胞黏附、分化和胞内信号转导等方面发挥着多样的生物学功能,而其抗病毒作用是当前研究的热点,不仅可通过多种途径阻止病毒的侵入,而且IFITMs基因多态性与病毒易感性及严重程度也具有一定相关性。本文对IFITM抗病毒相关研究进展进行综述。

关键词: 干扰素诱导跨膜蛋白, 抗病毒, 基因多态性

Abstract: Interferon (IFN),binding to celluar interferon receptor specifically after stimulation, can promote the expression of hundreds of interferon stimulated genes (ISGs) that encodes many antiviral innate immune effectors,thus stimulating or regulating the host's immune response. And interferon-induced transmembrane protein (IFITM) , an important immune molecule, is just one of ISGs expression products. IFITM have multiple biological functions, such as antiviral infection, involving in tumor formation ,regulating bone metabolism, adjusting cell adhesion, affecting cell differentiation, and even having a role in cell signal transduction.However,The antiviral effect of IFITM is one of hot spots in current research.Not only can IFITM prevent the invasion of the virus through a variety of ways, but also the genetic polymorphism of IFITM has a certain correlation with the susceptibility and severity of the virus.Here we reviewed the antiviral progress of IFITM.

Key words: Interferon-induced transmembrane protein, Antiviral, Gene polymorphism

李浩民, 吴诗品. 干扰素诱导跨膜蛋白的抗病毒研究进展[J]. 新发传染病电子杂志, 2020, 5(2): 122-125.

Li Haomin, Wu Shipin. Research on antiviral progress of interferon-induced transmembrane protein[J]. Electronic Journal of Emerging Infectious Diseases, 2020, 5(2): 122-125.

参考文献

[1] Friedman RL, Manly SP, McMahon M, et al. Transcriptional and posttranscriptionalregulation of interferon-induced gene expression in human cells[J]. Cell, 1984, 38(3):745-755.
[2] Hickford D, Frankenberg S, Shaw G, et al.Evolution of vertebrate interferon inducible transmembrane proteins[J]. BMC Genomics, 2012, 13(1):155.
[3] Zhang Z, Liu J, Li M, et al.Evolutionary dynamics of the interferon-induced transmembrane gene family in vertebrates[J]. PLoS One,2012,7(11):e49265.
[4] Yount JS,Moltedo B,Yang YY,et al Palmitoylome profilingreveals S-palmitoylation-dependent antiviral activity of IFITM3[J].Nat Chem Biol,2010,6(8) : 610–614.
[5] Yount JS,Karssemeijer RA,Hang HC.S-palmitoylation and ubiquitination differentially regulate interferon-induced transmembrane protein 3 ( IFITM3) -mediated resistance to influenza virus[J]. J Biol Chem, 2012, 287(23):19631-19641
[6] Bailey CC,Kondur HR,Huang IC,et al.Interferon-induced transmembraneprotein 3 is a type Ⅱ transmembrane protein[J]. J Biol Chem,2013,288( 45): 32184-32193
[7] Anafu AA, Bowen CH, Chin CR, et al.Interferon-inducible transmembrane protein 3 (IFITM3) restricts reovirus cell entry[J]. J Biol Chem, 2013, 288(24):17261-17271.
[8] Xu JF, Qian P, Wu QF, et al.Swine interferon-induced transmembrane protein, sIFITM3, inhibits foot-and-mouth disease virus infection in vitro and in vivo[J]. Antiviral research, 2014, 109(1): 22-29.
[9] Eric M, Feeley,Jennifer S, et al.(2013) IFITM proteins restrict viral membrane hemifusion[J]. PLoS Pathog, 2013, 9(1):e1003124
[12] Amini-Babil-Olyaee S, Choi YJ, Lee JH, et al. The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry[J]. Cell host & microbe, 2013, 13(4):452-464.
[13] Desia TM, Marin M, Chin CR, et al.IFITM3 restricts influenza A virus entry by blocking the formation of fusion pores following virus-endosome hemifusion[J]. PLoS pathogens, 2014, 10(4):e1004048.
[14] Alber D, Staeheli P.Partial inhibition of vesicular stomatitis virus by the interferon-induced human9-27 protein[J]. J Interferon Cytokine Res, 1996, 16(5):375-780.
[15] Brass AL, Huang IC, Benita Y, et al.The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus[J]. Cell, 2009, 139(7):1243-1254.
[16] Brass AL, Huang IC, Benita Y, et al.The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus[J]. Cell, 2009. 139(7):1243-1254.
[17] Huang IC, Bailey CC, Weyer JL, et al.Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus[J]. PLoS Pathog. 2011, 7(1):e1001258.
[18] Jiang D, Weidner JM, Qing M, et al.Identification of five interferon-induced cellular proteins that inhibit West Nile virus and dengue virus infections[J]. J Virol, 2010, 84(16):8332-8341.
[19] John SP, Chin CR, Perreira JM, et al.The CD225 domain of IFITM3 is required for both IFITM protein association and inhibition of influenza A virus and dengue virus replication[J]. J Virol, 2013, 87(14):7837-7852.
[20] Smith SE, Gibson MS, Wash RS, et al.Chicken interferon-inducible transmembrane protein 3 restricts influenza viruses and lyssaviruses in vitro[J]. J Virol, 2013, 87(23):12957-12966.
[21] Mudhasani R, Tran JP, Retterer C, et al.IFITM-2 and IFITM-3 but not IFITM-1 restrict Rift Valley fever virus[J]. J Virol, 2013, 87(15):8451-8464
[22] Wilkins C, Woodward J, Lau DT, et al.VIFITM1 is a tight junction protein that inhibits hepatitis C virus entry[J]. Hepatology, 2013, 57(8):461-469.
[23] Everitt AR, Clare S, McDonald JU, et al. Defining the range of pathogens susceptible to Ifitm3 restriction using a knockout mouse model[J]. PLoS One, 2013, 8(11):e80723.
[24] Anafu AA, Bowen CH, Chin CR, et al.Interferon-inducible transmembrane protein 3 (IFITM3) restricts reovirus cell entry[J]. J Biol Chem, 2013, 288(24):17261-17271.
[25] Everitt AR, Clare S, Pertel T, et al.IFITM3 restricts the morbidity andmortality associated with influenza[J]. Nature, 2012, 484(7395):519-523.
[26] Zhang YH, Zhao Y, Li N, et al.Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals[J]. Nat Commun, 2013, 4(1):1418
[27] Wang Z, Zhang A, Wan Y, et al.Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection[J]. Proc Natl Acad Sci, 2014, 111(2):769-774.
[28] Xianxian Y, Bin T, Xipeng Z, et al.Interferon-Inducible Transmembrane Protein 3 Genetic Variant rs12252 and Influenza Susceptibility and Severity: A Meta-Analysis[J]. PLoS One, 2015, 10(5):e0124985.
[29] 李丹丹. 干扰素诱导跨膜蛋白分子抗乙型肝炎病毒效果初探[D].安徽,安徽医科大学,2011:1-7.